2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Resolution to lift the non-competition restrictions for new directors

1.Date of the shareholders’ meeting resolution:2021/10/27 2.Name and title of the managerial officer with permission to engage in competitive conduct: Director        Tessie Che Director        Michael Chang, Representative of OBI Pharma Inc. Director        Frank Chen, Representative of OBI Pharma Inc. Director        Ming-Tain Lai, Representative […]

HOMEWhat’s NewAnnouncementsAnnouncement on behalf of major subsidiary, Amaran Biotechnology, Inc. of Resolution to lift the non-competition restrictions for new directors

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. of important resolutions of the 2021 annual shareholders’ meeting

2021.Oct.27

Announcement on behalf of major subsidiary, Amaran Biotechnology, Inc. that the Company’s Board of Directors resolved to appoint Ms. Tessie Che as Chairperson